Hepalife forte

Hepalife forte

Products

Information

Hepalife Forte is an advanced hepatoprotective supplement designed to support liver health and function. This new-generation product combines powerful ingredients known for their ability to protect liver cells, reduce inflammation, and promote liver regeneration. Unique formulation with PATENTED ACTIVE INGREDIENT - Siliphos® , SAMe, Choline, vitamin E and Vitamin B complex. Siliphos®, a clinically approved patented blend of silybin and phosphatidylcholine using Phytosome technology, offers a natural delivery system that enhances the bioavailability of silybin. The bioavailability of silybin from the phosphocomplex is 4.6 times higher than that of classical silymarin. Recommended Use: Hepalife Forte is recommended for individuals with liver conditions such as fatty liver disease, NAFLD and MAFLD, chronic hepatitis (Hepatitis B and C), liver damage due to alcohol or drugs, and as an ancillary therapy for liver cirrhosis. Its formulation supports liver function, helps in reducing oxidative stress, and prevents the progression of liver diseases. Hepalife Forte offers a comprehensive approach to liver care, combining the benefits of SAMe, silymarin, and phospholipids to support overall liver health and function.
RHEI LIFERhei Life is a dynamic pharmaceutical company with a strong global presence. Founded in 2015, Rhei Life began as a privately-owned pharma startup in Serbia and the UAE. Initially, the company focused on the Balkan markets, specializing in the importation of unregistered medicines and representing various pharmaceutical companies. Over the years, Rhei Life expanded its B2C and B2B operations to include European, Middle Eastern, North African, and Southeast Asian markets. We have established over 130 partnerships across 45+ countries, demonstrating our commitment to innovation and collaboration in the pharmaceutical industry. Supplier Network: We have forged active relationships with 76 suppliers from 32 countries. Customer Reach: Since our inception, we've engaged with over 72 customers from 34 countries. Industry Partners: Our partnerships include some of the largest pharmaceutical companies, such as Teva, Stada, Zentiva, Dr Reddy's, Sun Pharma, Walgreens Boots Alliance, Duopharma, Recordati Rare Diseases, Sinopharm, Hetero and others OWN MAS AND DISTRIBUTION : We collaborate with more than 25 manufacturers globally for our operations in over 10 East European markets, with 253 SKUs submitted to national authorities and 87 SKUs already granted European Operations for our in house developed retail B2B portfolio: Our products are manufactured through CDMOs facilities in 9 European countries: Italy, Spain, Serbia, Lithuania, Greece, Malta, Turkey, Ireland, and Romania.

Log in

See all the content and easy-to-use features by logging in or registering!